The clinical development process for central nervous system diseases is scientifically and medically complex. These studies struggle with low success rates due to various challenges.
Common CNS study challenges:
- Limited ability in determining treatment efficacy
- Subjective outcome measures
- High placebo response rates
Signant’s SmartSignals suite is tailored to address these challenges. With the help of the company’s digital tools and scientific experts, you’ll improve your data quality and signal detection.